Tissue distribution of benznidazole in chronically Trypanosoma cruzi infected mice

Vol. 1, 2019. - 119110
Pôster
Favorite this paper
How to cite this paper?
Abstract

The high therapeutic failure rate in chronic Chagas disease might be related to low distribution of benznidazole in the infected tissues by Trypanosoma cruzi. To date, there are no data regarding benzindazole tissue penetration in Chagas disease experimental models. Therefore, this study aimed to investigate the biodistribution of benznidazole in female Swiss mice chronically infected with Berenice-78 strain of Trypanosoma cruzi. After single oral dose of benznidazole 100 mg/Kg to mice (n=40), samples of brain, colon and heart were collected at intervals up to 12 hours (CEUA/UFOP nº 2016/58). Benznidazole tissues concentrations were measured using HPLC-DAD. The one-compartmental pharmacokinetics analyses showed that the brain was the organ with lowest exposure and peak concentration, followed by heart and colon. Benznidazole biodistribution was wide, with very low penetration ratios. These results indicate that the low tissue distribution of benznidazole could be a limiting factor in efficacy of Chagas disease treatment.

Institutions
  • 1 Núcleo de Pesquisas em Ciências Biológicas / Universidade Federal de Ouro Preto
  • 2 Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP)
Track
  • Pharmacology and Physiology
Keywords
Chagas disease
pharmacokinetics
Benznidazole